The Levofloxacin Sodium Chloride Injection independently researched and developed by Qidu Pharma is the first in China to be approved for marketing.Its drug approval number is H20203476 and H20203477.
On May 8, 2019, moxifloxacin hydrochloride and sodium chloride injection, the latest generation of quinolones antibacterial drug, independently researched and developed by Qidu Pharmaceutical Co., Ltd
From 25 to 28 December 2019, workshop 801 in Qidu Pharma, which produces PP ampoule, was under on-site inspection from GMP experts of Shandong Drug Administration.
From May 8 to 29, 2020, the second QA director training class of Qidu Pharmaceutical was successfully held. Chairman Zheng Jiaqing, General Manager Zhang Jianli, and other company leaders attended the
At present, Qidu Pharma has successfully passed the certification site inspections of "ISO45001 Occupational Health and Safety Management System" and "ISO50001 Energy Management System" organized by S